genechip human genome hg u95av2 oligonucleotide microarray (Thermo Fisher)
86
Structured Review
Thermo Fisher
genechip human genome hg u95av2 oligonucleotide microarray
Genechip Human Genome Hg U95av2 Oligonucleotide Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genechip+human+genome+hg+u95av2+oligonucleotide+microarray/pm18604784-31-9-15
Average 86 stars, based on 1 article reviews
Genechip Human Genome Hg U95av2 Oligonucleotide Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genechip+human+genome+hg+u95av2+oligonucleotide+microarray/pm18604784-31-9-15
Average 86 stars, based on 1 article reviews
genechip human genome hg u95av2 oligonucleotide microarray - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Microarray:Article Title: Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression. Article Snippet: S Hanada,1,5 A Maeshima,2,7 Y Matsuno,2,6 T Ohta,1 M Ohki,1 T Yoshida,1,3 Y Hayashi,4 Y Yoshizawa,5 S Hirohashi2 and M Sakamoto2,4* 1Center for Medical Genomics, National Cancer Center Research Institute, Tokyo, Japan 2Pathology Division, National Cancer Center Research Institute, Tokyo, Japan 3Genetic Division, National Cancer Center Research Institute, Tokyo, Japan 4Department of Pathology, Keio University School of Medicine, Tokyo, Japan 5Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan 6Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan 7Clinical Laboratory Division, National Hospital Organization Tokyo Medical Center, Tokyo, Japan Gene Expression:Article Title: Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression. Article Snippet: S Hanada,1,5 A Maeshima,2,7 Y Matsuno,2,6 T Ohta,1 M Ohki,1 T Yoshida,1,3 Y Hayashi,4 Y Yoshizawa,5 S Hirohashi2 and M Sakamoto2,4* 1Center for Medical Genomics, National Cancer Center Research Institute, Tokyo, Japan 2Pathology Division, National Cancer Center Research Institute, Tokyo, Japan 3Genetic Division, National Cancer Center Research Institute, Tokyo, Japan 4Department of Pathology, Keio University School of Medicine, Tokyo, Japan 5Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan 6Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan 7Clinical Laboratory Division, National Hospital Organization Tokyo Medical Center, Tokyo, Japan |